? A Series A extension: US-China biotech Degron Therapeutics has collected an additional $40 million for its molecular glue degrader platform. The San Diego and Shanghai biotech has raised $95 million …
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
